Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled study

Richard N. Channick(University of California, San Diego), G Simonneau(Hôpital Antoine-Béclère), Olivier Sitbon(Hôpital Antoine-Béclère), Ivan M. Robbins(Vanderbilt University), Adaani Frost(Baylor College of Medicine), Victor F. Tapson(Duke Medical Center), David B. Badesch(University of Colorado Health), Sébastiên Roux(Actelion (Switzerland)), Maurizio Rainisio, Frédéric Bodin(Actelion (Switzerland)), Lewis J. Rubin(University of California System)
The Lancet
October 1, 2001
Cited by 1,523

Abstract


Related Papers

No related papers found

Powered by citation graph analysis